JULIE JENKINS: Open Payments
NPI 1194178772 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 63 payments from 21 companies in 2025. Trend: 2023 $1,792 · 2024 $2,673 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 24 | $166 |
| BETA BIONICS, INC. | 5 | $131 |
| Medtronic, Inc. | 1 | $91 |
| Novo Nordisk Inc | 3 | $73 |
| Lilly USA, LLC | 4 | $72 |
| Xeris Pharmaceuticals, Inc. | 3 | $70 |
| Tandem Diabetes Care, Inc. | 2 | $51 |
| Corcept Therapeutics | 3 | $51 |
| Amgen Inc. | 2 | $45 |
| Dexcom, Inc. | 2 | $41 |
Products named: Kerendia, iLet Bionic Pancreas, SYMPLICITY G3, Ozempic, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, Korlym, GVOKE HYPOPEN.
Industry payments across AL — which companies pay providers there.
